Viðgerðin fyri bróstkrabba er treytað av ymiskum viðurskiftum, so sum, hvussu sjúkugongdin er, hvat slag av krabba talan er um, hvussu sjúklingurin er fyri og hvørjar persónligar ynski hann hevur.
Vanligir viðgerðarhættir eru:
1. Viðgerð: Viðgerð snýr seg um at taka vøksturin og tað sum er rundan um hann burtur.
Tað eru ymisk sløg av skurðviðgerð, eitt nú lumpectomi, mastectomi og lymfknøttum.
2. Strálulækning: Við strálulækning verður nógv orka brúkt til at drepa krabbameinsfrumur og minka um vøkstur.
Tað verður ofta brúkt eftir skurðviðgerð fyri at drepa møguligar verandi krabbameinsfrumur.
3. Kemoterapi: Her verður heilivágur brúktur til at drepa krabbameinssellur.
Tað kann verða givið í æð ella munnliga og verður ofta brúkt til at minka um vøkstur áðrenn skurðviðgerð ella til at drepa verandi krabbameinsfrumur eftir skurðviðgerð.
4. Hormonviðgerð: Hetta verður brúkt til hormonviðkvæman bróstkrabba og virkar við at steðga hormonunum, sum elva til vøkstur í krabbameinsfrumum.
5. Málrættað viðgerð: Viðgerðin viðger sjúku við heilivági, sum hevur til endamáls at raka ávísar molekyler, sum eru við til at fáa krabbameinsfrumurnar at vaksa og breiða seg.
6. Immunterapi: Hetta hjálpir immunverjuni at kenna krabbameinsfrumurnar aftur og at basa teimum.
7. Kliniskar royndir: Sjúklingar kunnu eisini umhugsa at luttaka í kliniskum royndum fyri at fáa atgongd til nýggjar og royndarviðgerðir.
Tað er umráðandi at tosa við heilsufrøðingin um, hvørjir møguleikar eru fyri at fáa bestu viðgerðina, tí viðgerðarætlanin verður lagað til tørvin og umstøðurnar hjá tí einstaka.
Harumframt kann stuðlandi viðgerð, sum t.d. pínuviðgerð, kensluligur stuðul og kostvegleiðing eisini vera partur av viðgerðarætlanini.
Kumar L, Baldi A, Verma S, Utreja P: Exploring Therapeutic Potential of Nanocarrier Systems Against Breast Cancer. Pharm Nanotechnol. 2018, 6 (2): 94-110.
Mehrgou A, Akouchekian M: Therapeutic impacts of microRNAs in breast cancer by their roles in regulating processes involved in this disease. J Res Med Sci. 2017, 22 (): 130.
Ng AK, Travis LB: Radiation therapy and breast cancer risk. J Natl Compr Canc Netw. 2009, 7 (10): 1121-8.
Ligresti G, Libra M, Militello L, Clementi S, Donia M, Imbesi R, Malaponte G, Cappellani A, McCubrey JA, Stivala F: Breast cancer: Molecular basis and therapeutic strategies (Review). Mol Med Rep. , 1 (4): 451-8.
Bricou A, Barranger E: Response to the article by Evangelista et al.: Use of a portable gamma camera for guiding surgical treatment in locally advanced breast cancer in a post-neoadjuvant therapy setting. Breast Cancer Res Treat 2014. Breast Cancer Res Treat. 2014, 148 (1): 231-2.
Daniyal A, Santoso I, Gunawan NHP, Barliana MI, Abdulah R: Genetic Influences in Breast Cancer Drug Resistance. Breast Cancer (Dove Med Press). 2021, 13 (): 59-85.
Li X, Bu X: Progress in Vaccine Therapies for Breast Cancer. Adv Exp Med Biol. 2017, 1026 (): 315-330.
['Avsakan: sjúkuviðurskifti']
['Henda heimasíðan er bert til undirvísingar og kunningar og er ikki ætlað sum læknalig ráðgeving ella faklig tænasta.']
['Upplýsingarnar eiga ikki at verða nýttar til at staðfesta ella viðgera nakran heilsutrupulleika ella sjúku, og tey, sum ynskja persónliga læknahjálp, eiga at venda sær til ein autoriseraðan lækna.']
['Gev gætur, at tað neuronala netið, sum gevur svar uppá spurningarnar, er serliga skeivt, tá ið talan er um talgilda innihaldið, t.d. talið av fólki, sum hava fingið staðfest eina ávísa sjúku.']
['Spyr altíð læknan ella annan skikkaðan heilsuhjálpara um ráðgeving í sambandi við sjúku. Vanvirð ongantíð professionella læknaráðgeving ella drála við at leita eftir henni vegna okkurt, tú hevur lisið á hesi heimasíðu.']
['Avsakan: upphavsrættur']
['Digital Millennium Copyright Act frá 1998, 17 U.S.C. § 512 (DMCA) gevur rætt til at kæra til rættindahavarar, sum halda, at tilfar, sum kemur á internetið, brýtur teirra rættindi sambært amerikanskum lógum um upphavsrætt. ']
['Um tú í góðari trúgv heldur, at eitthvørt innihald ella tilfar, sum er gjørt tøkt í sambandi við okkara heimasíðu ella tænastur, brýtur tíni upphavsrættindi, kanst tú (ella tín umboðsmaður) senda okkum eina fráboðan, har tú biður um, at innihaldið ella tilfarið verður tikið burtur ella atgongdin til tað verður sperrað.']
['Tilmeldingarnar skulu verða skrivligar við telduposti (sí "Kontakt" fyri teldupostadressu).']
['DMCA krevur, at fráboðan um meint brot á upphavsrættin skal innihalda hesar upplýsingar: (1) lýsing av tí upphavsrættarliga verkinum, sum talan er um, (2) lýsing av tí meinta brot á upphavsrættin og upplýsingar, sum eru nøktandi til at vit kunnu finna innihaldið (3) upplýsingar um teg, t.d. tín bústað, telefonnummar og teldupostbústað (4) eina váttan frá tær um, at tú í góðari trúgv heldur, at innihaldið, sum tú klagar um, ikki er loyvt av rættindahavanum ella umboði hansara ella sambært lóggávu']
['5) eina váttan frá tær, undirskrivað undir revsing fyri lygi, um, at upplýsingarnar í fráboðanini eru rættar, og at tú hevur heimild at gera galdandi upphavsrættin, sum verður hildin at vera brotin,']
['og 6) fysiska ella elektroniska undirskrift hjá rættindahavara ella persóni, sum hevur loyvi at virka fyri rættindahavara.']
['Um tú ikki hevur upplýst allar omanfyri nevndu upplýsingar, kann tað hava við sær, at viðgerðin av klaguni verður seinkað.']
['Set teg í samband við']
['Vinarliga send okkum ein teldupost við einum hvørjum spurningi/uppskoti.']
How to treat breast cancer?
The treatment for breast cancer depends on various factors such as the stage of cancer, the type of cancer, the patient's overall health, and personal preferences.
Some common treatment options include:
1. Surgery: This involves removing the tumor and surrounding tissue.
There are different types of surgery, including lumpectomy, mastectomy, and lymph node removal.
2. Radiation therapy: This uses high-energy radiation to kill cancer cells and shrink tumors.
It is often used after surgery to kill any remaining cancer cells.
3. Chemotherapy: This involves using drugs to kill cancer cells.
It can be given intravenously or or orally and is often used to shrink tumors before surgery or to kill any remaining cancer cells after surgery.
4. Hormone therapy: This is used for hormone-receptor-positive breast cancers and works by blocking the hormones that fuel the growth of cancer cells.
5. Targeted therapy: This uses drugs that target specific molecules involved in the growth and spread of cancer cells.
6. Immunotherapy: This helps the immune system recognize and attack cancer cells.
7. Clinical trials: Patients may also consider participating in clinical trials to access new and experimental treatments.
It is important to discuss the best treatment options with a healthcare team, as the treatment plan will be tailored to the individual's specific needs and circumstances.
Additionally, supportive care such as pain management, emotional support, and nutritional guidance may also be part of the treatment plan.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Umleið']
['BioMedLib nýtir sjálvvirkandi teldur (maskinlæringaralgoritmur) til at gera spurningar og svar.']
['Vit byrja við 35 milliónum av biomedicinskum útgávum frá PubMed/Medline. eisini heimasíðum frá RefinedWeb.']
